UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.01B |
| 2 |
Microsoft
MSFT
|
+$922M |
| 3 |
Amazon
AMZN
|
+$646M |
| 4 |
Tesla
TSLA
|
+$554M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$496M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$1.04B |
| 2 |
Linde
LIN
|
+$949M |
| 3 |
ExxonMobil
XOM
|
+$313M |
| 4 |
VMW
VMware, Inc
VMW
|
+$217M |
| 5 |
NVIDIA
NVDA
|
+$205M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.4% |
| 2 | Healthcare | 13.37% |
| 3 | Consumer Discretionary | 11.23% |
| 4 | Financials | 10.99% |
| 5 | Communication Services | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AAN
2351
DELISTED
The Aaron's Company Inc
AAN
| $325K | ﹤0.01% |
31,076
-10,418
| -25% | -$133K |
|
2352
LivePerson
LPSN
$21.8M
| $325K | ﹤0.01% |
5,575
+363
| +7% | +$23.9K |
|
2353
Zai Lab
ZLAB
$2.06B
| $324K | ﹤0.01% |
13,318
-444,980
| -97% | -$11.9M |
|
2354
Baytex Energy
BTE
$3.25B
| $321K | ﹤0.01% |
+72,765
| New | +$286K |
|
2355
TaskUs
TASK
$556M
| $320K | ﹤0.01% |
30,804
+18,453
| +149% | +$198K |
|
2356
Enel Chile
ENIC
$6.14B
| $318K | ﹤0.01% |
107,316
+54,194
| +102% | +$178K |
|
2357
AngioDynamics
ANGO
$611M
| $316K | ﹤0.01% |
43,277
-8,674
| -17% | -$72.2K |
|
2358
American Well
AMWL
$180M
| $314K | ﹤0.01% |
13,436
-93,200
| -87% | -$3.15M |
|
2359
FuboTV Inc
FUBO
$261M
| $314K | ﹤0.01% |
9,804
+1,731
| +21% | +$53.6K |
|
2360
Future Fuel
FF
$217M
| $312K | ﹤0.01% |
43,505
| – | – |
|
2361
Children's Place
PLCE
$54.3M
| $312K | ﹤0.01% |
11,534
-126,682
| -92% | -$3.44M |
|
|
SFIX
2362
Stitch Fix
SFIX
$536M
| $311K | ﹤0.01% |
90,038
| – | – |
|
2363
Mission Produce
AVO
$1.11B
| $309K | ﹤0.01% |
31,963
| – | – |
|
2364
ImmunityBio
IBRX
$7.51B
| $309K | ﹤0.01% |
182,930
| – | – |
|
2365
Magnachip Semiconductor
MX
$119M
| $308K | ﹤0.01% |
37,071
| – | – |
|
2366
Donegal Group Class A
DGICA
$731M
| $307K | ﹤0.01% |
21,527
| – | – |
|
2367
Vanda Pharmaceuticals
VNDA
$307M
| $307K | ﹤0.01% |
71,000
-12,309
| -15% | -$68.4K |
|
|
BZUN
2368
Baozun
BZUN
$167M
| $306K | ﹤0.01% |
98,641
| – | – |
|
2369
Domo
DOMO
$174M
| $305K | ﹤0.01% |
31,092
-4,373
| -12% | -$60.8K |
|
2370
Mitek Systems
MITK
$754M
| $304K | ﹤0.01% |
28,399
| – | – |
|
2371
Forrester Research
FORR
$223M
| $304K | ﹤0.01% |
10,525
+3,213
| +44% | +$98.9K |
|
2372
AnaptysBio
ANAB
$1.58B
| $304K | ﹤0.01% |
16,921
| – | – |
|
|
VTNR
2373
DELISTED
Vertex Energy, Inc
VTNR
| $302K | ﹤0.01% |
67,800
+8,556
| +14% | +$43.9K |
|
2374
4D Molecular Therapeutics
FDMT
$532M
| $300K | ﹤0.01% |
23,588
+13,439
| +132% | +$225K |
|
2375
Blink Charging
BLNK
$74.3M
| $300K | ﹤0.01% |
98,012
+68,344
| +230% | +$344K |
|
Similar funds
UBS AM's Q3 2023 Portfolio in Review
As of Q3 2023, UBS AM held 2,762 positions worth $223B, up 8.1% from $206B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
UBS AM deployed $7.28B of net new capital in Q3 2023, opening 89 new positions and adding to 1,400 existing holdings. Its largest new stake was Kenvue: 8,680,819 shares worth $174M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Abbott, an estimated $1.04B trimmed.
- UBS AM's largest Q3 2023 buy was Kenvue: 8,680,819 shares worth $174M.
- UBS AM added most to Apple in Q3 2023, an estimated $1.01B increase.
- UBS AM's biggest Q3 2023 reduction was Abbott, cutting an estimated $1.04B.
- UBS AM fully exited World Wrestling Entertainment in Q3 2023, selling an estimated $128M.
- UBS AM's ten largest holdings make up 26% of its $223B portfolio in Q3 2023.
- UBS AM opened 89 new positions and closed 174 in Q3 2023.
- UBS AM's portfolio value rose 8.1% quarter-over-quarter to $223B.
Based on UBS AM's 13F filing for Q3 2023, filed 13 Nov 2023.